Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2681 |
|
| Actual shortage: | 255 (10%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2417 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
23 (9%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACT QUETIAPINE | 25MG | TABLET | Resolved | 2021-03-04 | 2021-04-21 | 135129 |
| TEVA-AMPHETAMINE XR | 25MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2021-03-25 | 2021-05-20 | 136286 |
| TEVA-INDOMETHACIN | 25MG | CAPSULE | Resolved | 2021-03-25 | 2021-04-15 | 136320 |
| TEVA-SUMATRIPTAN DF | 25MG | TABLET | Resolved | 2021-03-25 | 2021-04-01 | 136326 |
| TEVA-LOSARTAN | 25MG | TABLET | Resolved | 2021-04-29 | 2024-04-01 | 138306 |
| TEVA-LOSARTAN | 25MG | TABLET | Resolved | 2021-05-13 | 2021-05-20 | 139306 |
| TEVA-HYDROCHLOROTHIAZIDE | 25MG | TABLET | Resolved | 2021-06-10 | 2021-07-15 | 140690 |
| TEVA-AMITRIPTYLINE | 25MG | TABLET | Resolved | 2021-06-24 | 2022-01-07 | 141466 |
| TEVA-SILDENAFIL | 25MG | TABLET | Resolved | 2021-09-02 | 2021-09-23 | 145121 |
| ACT EXEMESTANE | 25MG | TABLET | Resolved | 2021-09-23 | 2021-11-18 | 146089 |
| FLUDARABINE PHOSPHATE FOR INJECTION | 25MG | SOLUTION | Resolved | 2021-11-11 | 2021-12-11 | 149108 |
| TEVA-DICLOFENAC EC | 25MG | TABLET (ENTERIC-COATED) | Resolved | 2021-12-17 | 2022-02-05 | 151453 |
| TEVA-PREGABALIN | 25MG | CAPSULE | Resolved | 2022-01-20 | 2022-04-01 | 153183 |
| TEVA-AMPHETAMINE XR | 25MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2022-02-17 | 2022-04-21 | 155134 |
| TEVA-PREGABALIN | 25MG | CAPSULE | Resolved | 2022-06-09 | 2023-06-09 | 162254 |
| TEVA-CARVEDILOL | 25MG | TABLET | Resolved | 2022-06-16 | 2022-08-09 | 162852 |
| ACT QUETIAPINE | 25MG | TABLET | Resolved | 2022-07-25 | 2023-01-19 | 165453 |
| TEVA-SPIRONOLACTONE | 25MG | TABLET | Resolved | 2022-08-18 | 2023-04-28 | 167212 |
| ACT EXEMESTANE | 25MG | TABLET | Resolved | 2022-09-22 | 2023-01-19 | 170011 |
| TEVA-INDOMETHACIN | 25MG | CAPSULE | Resolved | 2022-10-17 | 2023-06-09 | 172010 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63937 | ||
| DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63940 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-12 | 2018-10-12 | 63952 | ||
| GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63967 | ||
| GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63970 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64520 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64526 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64529 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64532 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64535 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64544 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64547 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64550 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64553 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
| RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64595 | ||
| RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64598 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64615 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64623 |